Jpmorgan Chase & CO Lexicon Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 87,617 shares of LXRX stock, worth $64,836. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,617

Previous 89,700 2.32%

Holding current value

$64,836

Previous $140,000 54.29%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$0.65 - $2.08 $1,353 - $4,332	-2,083 Reduced 2.32%	87,617 $64,000
Q3 2024 Dec 26, 2024	SELL	$1.51 - $2.39 $1,096 - $1,735	-726 Reduced 0.8%	89,700 $140,000
Q3 2024 Nov 08, 2024	SELL	$1.51 - $2.39 $1,096 - $1,735	-726 Reduced 0.8%	89,700 $140,000
Q2 2024 Dec 26, 2024	BUY	$1.54 - $2.28 $1,118 - $1,655	726 Added 0.81%	90,426 $151,000
Q2 2024 Aug 12, 2024	BUY	$1.54 - $2.28 $446 - $661	290 Added 0.32%	90,426 $151,000
Q1 2024 Dec 26, 2024	BUY	$1.3 - $3.58 $566 - $1,560	436 Added 0.49%	90,136 $216,000
Q1 2024 May 10, 2024	SELL	$1.3 - $3.58 $3.84 Million - $10.6 Million	-2,953,155 Reduced 97.04%	90,136 $216,000
Q4 2023 Dec 26, 2024	BUY	$1.0 - $1.53 $2.95 Million - $4.52 Million	2,953,591 Added 3292.74%	3,043,291 $4.66 Million
Q4 2023 Feb 12, 2024	BUY	$1.0 - $1.53 $228,257 - $349,233	228,257 Added 8.11%	3,043,291 $4.66 Million
Q3 2023 Nov 14, 2023	SELL	$1.06 - $2.33 $123,103 - $270,594	-116,135 Reduced 3.96%	2,815,034 $3.07 Million
Q2 2023 Aug 11, 2023	SELL	$2.15 - $3.49 $805,867 - $1.31 Million	-374,822 Reduced 11.34%	2,931,169 $6.71 Million
Q1 2023 May 18, 2023	BUY	$1.99 - $2.68 $126,952 - $170,970	63,795 Added 1.97%	3,305,991 $8.03 Million
Q1 2023 May 11, 2023	SELL	$1.99 - $2.68 $68,857 - $92,733	-34,602 Reduced 1.06%	3,242,196 $7.88 Million
Q4 2022 Feb 13, 2023	BUY	$1.8 - $2.56 $90,657 - $128,934	50,365 Added 1.56%	3,276,798 $6.26 Million
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $4.06 Million - $7.18 Million	2,093,656 Added 184.83%	3,226,433 $7.74 Million
Q2 2022 Aug 11, 2022	BUY	$1.31 - $2.69 $4,527 - $9,296	3,456 Added 0.31%	1,132,777 $2.11 Million
Q1 2022 May 11, 2022	SELL	$1.95 - $3.89 $36,599 - $73,011	-18,769 Reduced 1.63%	1,129,321 $2.36 Million
Q4 2021 Feb 10, 2022	SELL	$3.81 - $6.16 $36,625 - $59,216	-9,613 Reduced 0.83%	1,148,090 $4.52 Million
Q3 2021 Nov 12, 2021	BUY	$3.38 - $5.35 $3.91 Million - $6.19 Million	1,157,703 New	1,157,703 $5.57 Million

Others Institutions Holding LXRX

# of Institutions

134

Shares Held

239M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $140M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Lexicon Pharmaceuticals, Inc. Transaction History